Nutrigenomics Market to Reach USD 1.85 Billion by 2034, Growing

Nutrigenomics Market to Reach USD 1.85 Billion by 2034, Growing

Nutrigenomics Market to Reach USD 1.85 Billion by 2034, Growing

Nutrigenomics Market

Subheadline:
Rising awareness of gene-based nutrition, rapid growth in DNA testing, and the integration of AI-driven diet analytics are accelerating global expansion of the nutrigenomics market.

Download Full PDF Sample Copy of Market Report @

https://exactitudeconsultancy.com/request-sample/72618

Introduction

The Nutrigenomics Market is transforming how people approach health, wellness, and disease prevention.

Valued at USD 760 million in 2024, the market is projected to reach USD 1.85 billion by 2034, registering a CAGR of 9.2% during the forecast period.

Nutrigenomics-an emerging science that studies the interaction between genes, diet, and metabolism-enables the development of personalized nutrition plans that optimize health outcomes. Increasing prevalence of obesity, cardiovascular disease, and metabolic syndrome is fueling demand for gene-guided dietary interventions worldwide.

Key Players in the Market

The competitive ecosystem includes genetics startups, diagnostics providers, and established life-science companies investing in DNA-based nutrition testing.

Major players include:

• 23andMe Inc.

• Nutrigenomix Inc.

• DNAfit Life Sciences Ltd.

• GX Sciences Inc.

• Metagenics Inc.

• Nutrigenetics Ltd.

• GENEWAY SA

• Viome Life Sciences Inc.

• BASF SE (Human Nutrition Division)

• Wellness Genetics LLC

These companies are expanding portfolios to include AI-enhanced diet platforms, genomic databases, and microbiome-integrated testing for improved accuracy and personalization.

Explore Full Report here:

https://exactitudeconsultancy.com/reports/72618/nutrigenomics-market

Key Events in the Last Five Years

• 2020-2021: Pandemic-driven focus on immune health accelerated demand for nutrition-genomics kits and home saliva testing.

• 2022: 23andMe integrated wellness insights into its direct-to-consumer genetic reports.

• 2023: Viome Life Sciences launched the “Health Intelligence Test” combining microbiome and human gene expression analysis.

• 2024: AI-powered nutritional analytics platforms began partnering with healthcare providers for preventive nutrition programs.

Market Growth Rate

According to Exactitude Consultancy, the nutrigenomics market is expected to grow at a CAGR of 9.2% (2025-2034), propelled by:

• Rising consumer interest in personalized wellness.

• Advances in genomic sequencing technologies lowering testing costs.

• Expansion of digital health ecosystems integrating nutrition tracking and genetic data.

• Supportive government and research funding for preventive healthcare solutions.

Market Segments and Growth Analysis

The market is segmented by product type, application, and region.

By Product Type:

• Test Kits and Reagents

• Bioinformatics Platforms

• Services (Genetic Analysis and Nutritional Counseling)

By Application:

• Obesity Management

• Cardiovascular Health

• Diabetes and Metabolic Disorders

• Cancer Nutrition Support

• Anti-Aging and Sports Performance

• General Wellness and Preventive Care

By Region:

• North America: Largest share; strong adoption of DNA-based diet programs and health-tech innovation.

• Europe: Increasing regulatory focus on nutrigenetic testing quality and privacy compliance.

• Asia Pacific: Fastest-growing region, driven by rising middle-class health awareness and digital diagnostic startups.

• Latin America & MEA: Emerging market for personalized weight-management solutions.

Get Your Exclusive Offer with up to 10% Discount :

https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72618

Key Market Drivers

1. Personalized Nutrition Demand:

Consumers are shifting from generic diet plans to gene-tailored meal strategies enhancing nutrient absorption and disease resistance.

2. Technological Advancement:

Next-generation sequencing (NGS) and bioinformatics improve genetic variant interpretation and report turnaround time.

3. AI and Machine Learning Integration:

Predictive models optimize diet plans using real-time biomarker data.

4. Preventive Healthcare Focus:

Governments and insurers increasingly promote nutrigenomics for long-term cost reduction in chronic disease management.

Recent Developments

• 2023: Nutrigenomix launched an expanded 70-gene panel for personalized dietary assessment.

• 2024: BASF Human Nutrition unveiled AI-based platforms for micronutrient recommendations in functional foods.

• 2024: DNAfit integrated wearable data with genetic insights for dynamic health coaching.

• 2024: Viome secured major funding to scale personalized supplements manufactured from individual genomic and microbiome profiles.

Expert Insight

“The convergence of nutrigenomics, AI, and digital health tracking is reshaping preventive medicine. We’re entering an era where every meal can be genetically optimized for long-term wellness,”

– Dr. Amelia Lopez, Clinical Genomics Director, Harvard School of Public Health.

Conclusion

The Nutrigenomics Market stands at the intersection of genetics, nutrition, and data science, heralding a future of truly individualized healthcare.

With growing consumer adoption, falling sequencing costs, and advances in bioinformatics, nutrigenomics is evolving from niche science into mainstream wellness.

As AI-powered analytics refine dietary personalization, the market is poised for dynamic growth and deeper integration into global preventive-care frameworks by 2034.

This report is also available in the following languages : Japanese (ニュートリゲノミクス市場), Korean (영양유전체학 시장), Chinese (营养基因组学市场), French (Marché de la nutrigénomique), German (Nutrigenomik-Markt), and Italian (Mercato della nutrigenomica), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @

https://exactitudeconsultancy.com/request-sample/72618

Our More Reports:

Cell and Gene Therapy Manufacturing Market

https://exactitudeconsultancy.com/reports/72365/cell-and-gene-therapy-manufacturing-market

Joint Pain Injections Market

https://exactitudeconsultancy.com/reports/72379/joint-pain-injections-market

Medical Tourism Market

https://exactitudeconsultancy.com/reports/72397/medical-tourism-market

Compounding Pharmacy Market

https://exactitudeconsultancy.com/reports/72405/compounding-pharmacy-market

About Us

Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:

Irfan Tamboli

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: [email protected]

This release was published on openPR.

link

Leave a Reply

Your email address will not be published. Required fields are marked *